ABIO-FORM 8-K YEAR END RESULTS

Company

Oruka Therapeutics, Inc.

Filed

March 21, 2017

Period of Report

March 21, 2017

Accession Number

0001564590-17-004905

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →